Navigation Links
Web Page to Warn Against Online Purchase of Isotretinoin

On Wednesday, the FDA launched a special Web page. This web page is aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche// under the brand name Accutane, on the Internet.

The drug claims to cure severe acne that is not controlled by other treatment forms. FDA warns that if used improperly, the drug causes birth defects and severe mental health problems.

The FDA warning page appears in online search results for Accutane (isotretinoin) or its other generic versions(Amnesteem, Claravis, or Sotret) FDA advises that this drug be taken only under the direction of a physician or a pharmacist.

Isotretinoin manufacturers have already issued safeguards to reduce the risks of the drug, like the iPLEDGE risk management program. They warn women using isotretinoin to stop using the drug in case of pregnancy and pregnant women not to use isotretinoin.

Research studies have revealed that isotretinoin causes severe side effects in expectant mothers, such as birth defects and fetal death, and also might cause depression and suicide.

FDA data released in 2004 showed that these measures had little effect on the number of pregnant women taking the drug.

The FDA began to register physicians, prescription drug wholesalers, pharmacists and women into iPledge, since Dec. 30, 2005, which asks women to submit two negative pregnancy tests in order to receive a prescription for isotretinoin.

Women have to undergo a pregnancy test every month and must accept to use two different forms of birth control at the time of treatment with isotretinoin and for one month after treatment has ended, according to FDA.

Women also have to sign a text to acknowledge that isotretinoin can amplify risk for birth defects, depression and suicidal thoughts. About 165,000 people have registered with iPledge, which FDA administers jointly with companies that sell the drug.

The Web page was launched as FDA officials' felt that some are purchasing the drug on line to avoid involvement in iPledge.

The Web page has links to other info about the drug, including a link to iPledge. The Web page gets connected when people search for Accutane, or any of its three generic versions -- Amnesteem from Mylan Laboratories, Claravis from Barr Pharmaceuticals and Sotret from Ranbaxy Laboratories.
PRI
'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. New Weapon Against Germs
4. Estrogen Found To Protect the Colon Against Cancer
5. Diet Found To Offer Protection Against Leukemia
6. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
7. WHO Issues Caution Against Bird Flu Epidemic
8. New Supplement Found To Be Effective Against Sunburn
9. Intense Fight Against Polio In India Gets Results
10. Prime Minister Manmohan Against Incentive-Based Population Control
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: